LCD conference next Thursday15 Feb 2024 13:49
Could say something about the consultation in progress. Likely to get on the radar of big pharma if it isn't already. All small pharma have debt. The question is will they be in a position to attract major investment. Big pharma buy out promising small pharma all the time. Usually at phase 3 trials. This is tried and tested and approved. In the final hurdle to get onto Medicare properly and substantially. It will save the US billions in lost productivity and it will extend lives and quality of lives by averting serious kidney disease. It's worth a few billion not £1hundred million.
The debt is beside the point. The US will keep buying. Might take a hit tonight, might not. Within a few months this could be £1.00.